Trends in radiation dose and technique for anal canal squamous cell carcinoma.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.4_suppl.621
Abstract: 621 Background: Anal canal squamous cell carcinoma (SCC) is managed definitively with chemo and XRT, reserving surgery for salvage. Many different radiation dose schemes have been used, varying from 30 Gy to doses exceeding 60… read more here.
Keywords: anal canal; cell carcinoma; dose escalation; canal squamous ... See more keywords
Neoadjuvant PD-1 blockade combined with chemotherapy followed by concurrent immunoradiotherapy for locally advanced anal canal squamous carcinoma patients: Antitumor efficacy, safety and biomarker.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.e15500
Abstract: e15500 Background: Efficacy and safety of PD-1 inhibitors have been approved for the treatment of metastatic anal squamous cancer patients, but the efficacy of neoadjuvant treatment with PD-1 in anal squamous cancer patients has not… read more here.
Keywords: anal canal; squamous carcinoma; locally advanced; advanced anal ... See more keywords
Local excision for patients with stage I anal canal squamous cell carcinoma can be curative.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of gastrointestinal oncology"
DOI: 10.21037/jgo.2018.12.12
Abstract: Background Definitive concurrent chemoradiation is the current standard of care for all stage I anal canal squamous cell carcinoma. Local excision as primary treatment for selected stage I lesions has been reported in the literature… read more here.
Keywords: anal canal; stage anal; excision; canal squamous ... See more keywords